Business Description
Nanosphere Health Sciences Inc
NAICS : 325414
SIC : 3741
ISIN : CA63010P1009
Compare
Compare
Traded in other countries / regions
NSHS.Canada2CG.GermanyNSHSF.USA IPO Date
2017-11-30Description
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -88.96 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 38 | |||||
3-Year EPS without NRI Growth Rate | 40.8 | |||||
3-Year FCF Growth Rate | 14 | |||||
3-Year Book Growth Rate | 16.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.13 | |||||
9-Day RSI | 36.36 | |||||
14-Day RSI | 42.09 | |||||
6-1 Month Momentum % | 833.33 | |||||
12-1 Month Momentum % | 522.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -842.11 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.21 | |||||
EV-to-EBITDA | -1.21 | |||||
EV-to-FCF | -10.26 | |||||
Earnings Yield (Greenblatt) % | -82.64 | |||||
FCF Yield % | -9.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanosphere Health Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.017 | ||
Beta | 15.41 | ||
Volatility % | 435.6 | ||
14-Day RSI | 42.09 | ||
14-Day ATR (€) | 0.002435 | ||
20-Day SMA (€) | 0.02355 | ||
12-1 Month Momentum % | 522.22 | ||
52-Week Range (€) | 0.0005 - 0.039 | ||
Shares Outstanding (Mil) | 10.28 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanosphere Health Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanosphere Health Sciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Nanosphere Health Sciences Inc Frequently Asked Questions
What is Nanosphere Health Sciences Inc(FRA:2CG)'s stock price today?
The current price of FRA:2CG is €0.02. The 52 week high of FRA:2CG is €0.04 and 52 week low is €0.00.
When is next earnings date of Nanosphere Health Sciences Inc(FRA:2CG)?
The next earnings date of Nanosphere Health Sciences Inc(FRA:2CG) is .
Does Nanosphere Health Sciences Inc(FRA:2CG) pay dividends? If so, how much?
Nanosphere Health Sciences Inc(FRA:2CG) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |